English

Legend Biotech Corporation

EDGAR

LEGN Report (type unavailable) · filed 2026-09-25

Annual consolidated revenue for 2025: about USD 1.029B, using the latest reported figures. The previous period, 2024, was about USD 627.3M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

388 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 387500000 USD Source

Operating margin

14.89%

2026 Q2 · %

Exact inputs and evidence

Operating Income: 57700000 USD Source
Revenue: 387500000 USD Source

Operating cash flow

-20.9 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -106000000 USD Source
Operating Cash Flow: -85100000 USD Source

Free cash flow

-28.4 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -106000000 USD Source
Operating Cash Flow: -85100000 USD Source
Capital Expenditure: 15000000 USD Source
Capital Expenditure: 7500000 USD Source

Cash and cash equivalents: 673 million USD 2026-06-30 Source
Exact value

672900000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.27 billion USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 272330000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 1028900000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 722523000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 305100000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 387500000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-218 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence

Net income: -77989000 USD · 2024-01-01 – 2024-06-30 Source
Net income: -59793000 USD · 2024-01-01 – 2024-03-31 Source
Net income: -203310000 USD · 2024-01-01 – 2024-09-30 Source
Net income: -77989000 USD · 2024-01-01 – 2024-06-30 Source
Net income: -177026000 USD · 2024-01-01 – 2024-12-31 Source
Net income: -203310000 USD · 2024-01-01 – 2024-09-30 Source
Net income: -100916000 USD · 2025-01-01 – 2025-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-09-25.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2025-12-31
Operating income: 3 of 11 periods available· newest 2025-12-31
Net income: 7 of 11 periods available· newest 2024-12-31
Operating cash flow: 8 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2025-12-31
Total assets: 7 of 11 periods available· newest 2025-12-31
Total liabilities: 7 of 11 periods available· newest 2025-12-31
Current assets: 7 of 11 periods available· newest 2025-12-31
Current liabilities: 7 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+64%

Prior period

USD 627.3 million

2024-01-01 – 2024-12-31
Current period

USD 1.03 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

1028900000 − 627300000 = 401600000 USD

627300000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1028900000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Legend Biotech Corporation · 2025-12-31 Legend Biotech Corporation (edgar:1801198) Year-over-year change in Revenue: 401600000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1028900000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2866864 Filing: 000180119826000008 Input fundies:Revenue: 627300000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2867823 Filing: 000180119826000008
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 43.8 million

Prior period

−USD 144 million

2024-01-01 – 2024-12-31
Current period

−USD 100.2 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-100200000 − -144000000 = 43800000 USD

-144000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-100200000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Legend Biotech Corporation · 2025-12-31 Legend Biotech Corporation (edgar:1801198) Year-over-year change in Operating cash flow: 43800000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -100200000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2551089 Filing: 000180119826000008 Input fundies:OperatingCashFlow: -144000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2552022 Filing: 000180119826000008
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+102.8%

Prior period

USD 14.1 million

2024-01-01 – 2024-12-31
Current period

USD 28.6 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

28600000 − 14100000 = 14500000 USD

14100000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
28600000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Legend Biotech Corporation · 2025-12-31 Legend Biotech Corporation (edgar:1801198) Year-over-year change in Capital expenditure: 14500000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 28600000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2560635 Filing: 000180119826000008 Input fundies:CapitalExpenditure: 14100000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2561421 Filing: 000180119826000008
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 1.03 billion 100% of revenue
Operating costs Derived USD 1.17 billion 113% of revenue
Operating income −USD 136.5 million −13% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow −USD 100.2 million −9.7% of revenue
Capital expenditure USD 28.6 million 2.8% of revenue
Free cash flow Derived −USD 128.8 million −13% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.
2020 Not shown: operating income or net income is not reported.
2021 Not shown: operating income or net income is not reported.
2022 Not shown: operating income or net income is not reported.
2023 Operating loss: operating costs were 285% of revenue.
2024 Operating loss: operating costs were 149% of revenue.
2025 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2018 2018-01-01 – 2018-12-31	49133000	Unavailable	Unavailable	Unavailable	-2784000	286724000 Derived	Source 2018-01-01 – 2018-12-31: 49133000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -2784000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 307682000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 20958000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	59980000	Unavailable	Unavailable	Unavailable	-101590000	-109838000 Derived	Source 2019-01-01 – 2019-12-31: 59980000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -101590000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -83065000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 26773000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	75000000	Unavailable	Unavailable	Unavailable	-266373000	-249259000 Derived	Source 2020-01-01 – 2020-12-31: 75000000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -266373000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -223005000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 26254000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	68826000	Unavailable	Unavailable	Unavailable	-403582000	-240662000 Derived	Source 2021-01-01 – 2021-12-31: 68826000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -403582000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -198465000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 42197000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	117005000	Unavailable	Unavailable	Unavailable	-446349000	-222208000 Derived	Source 2022-01-01 – 2022-12-31: 117005000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -446349000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -201281000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 20927000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	285100000	813200000 Derived	-528100000	-9846000 Derived	-518254000	-413400000 Derived	Source 2023-01-01 – 2023-12-31: 285100000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -528100000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -518254000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -393300000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 20100000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	627300000	936800000 Derived	-309500000	-132474000 Derived	-177026000	-158100000 Derived	Source 2024-01-01 – 2024-12-31: 627300000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -309500000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -177026000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -144000000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 14100000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	1028900000	1165400000 Derived	-136500000	Unavailable	Unavailable	-128800000 Derived	Source 2025-01-01 – 2025-12-31: 1028900000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -136500000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -100200000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 28600000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1B 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Revenue	49133000	Revenue: 49133000 Open source
20192019-12-31	Revenue	59980000	Revenue: 59980000 Open source
20202020-12-31	Revenue	75000000	Revenue: 75000000 Open source
20212021-12-31	Revenue	68826000	Revenue: 68826000 Open source
20222022-12-31	Revenue	117005000	Revenue: 117005000 Open source
20232023-12-31	Revenue	285100000	Revenue: 285100000 Open source
20242024-12-31	Revenue	627300000	Revenue: 627300000 Open source
20252025-12-31	Revenue	1028900000	Revenue: 1028900000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

64% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Year over year	No prior comparable period	Revenue: 49133000 Open source
20192019-12-31	Year over year	22.1%	Revenue: 59980000 Open source Revenue: 49133000 Open source
20202020-12-31	Year over year	25%	Revenue: 75000000 Open source Revenue: 59980000 Open source
20212021-12-31	Year over year	-8.2%	Revenue: 68826000 Open source Revenue: 75000000 Open source
20222022-12-31	Year over year	70%	Revenue: 117005000 Open source Revenue: 68826000 Open source
20232023-12-31	Year over year	143.7%	Revenue: 285100000 Open source Revenue: 117005000 Open source
20242024-12-31	Year over year	120%	Revenue: 627300000 Open source Revenue: 285100000 Open source
20252025-12-31	Year over year	64%	Revenue: 1028900000 Open source Revenue: 627300000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -13.3% 2025

Net margin -28.2% 2024

Free cash flow margin -12.5% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2018-12-31	Operating margin	Not reported	Revenue: 49133000 Open source
2019-12-31	Operating margin	Not reported	Revenue: 59980000 Open source
2020-12-31	Operating margin	Not reported	Revenue: 75000000 Open source
2021-12-31	Operating margin	Not reported	Revenue: 68826000 Open source
2022-12-31	Operating margin	Not reported	Revenue: 117005000 Open source
20232023-12-31	Operating margin	-185.2%	Operating Income: -528100000 Open source Revenue: 285100000 Open source
20242024-12-31	Operating margin	-49.3%	Operating Income: -309500000 Open source Revenue: 627300000 Open source
20252025-12-31	Operating margin	-13.3%	Operating Income: -136500000 Open source Revenue: 1028900000 Open source
20182018-12-31	Net margin	-5.7%	Net Income: -2784000 Open source Revenue: 49133000 Open source
20192019-12-31	Net margin	-169.4%	Net Income: -101590000 Open source Revenue: 59980000 Open source
20202020-12-31	Net margin	-355.2%	Net Income: -266373000 Open source Revenue: 75000000 Open source
20212021-12-31	Net margin	-586.4%	Net Income: -403582000 Open source Revenue: 68826000 Open source
20222022-12-31	Net margin	-381.5%	Net Income: -446349000 Open source Revenue: 117005000 Open source
20232023-12-31	Net margin	-181.8%	Net Income: -518254000 Open source Revenue: 285100000 Open source
20242024-12-31	Net margin	-28.2%	Net Income: -177026000 Open source Revenue: 627300000 Open source
2025-12-31	Net margin	Not reported	Revenue: 1028900000 Open source
20182018-12-31	Free cash flow margin	583.6%	Revenue: 49133000 Open source Operating Cash Flow: 307682000 Open source Capital Expenditure: 20958000 Open source
20192019-12-31	Free cash flow margin	-183.1%	Revenue: 59980000 Open source Operating Cash Flow: -83065000 Open source Capital Expenditure: 26773000 Open source
20202020-12-31	Free cash flow margin	-332.3%	Revenue: 75000000 Open source Operating Cash Flow: -223005000 Open source Capital Expenditure: 26254000 Open source
20212021-12-31	Free cash flow margin	-349.7%	Revenue: 68826000 Open source Operating Cash Flow: -198465000 Open source Capital Expenditure: 42197000 Open source
20222022-12-31	Free cash flow margin	-189.9%	Revenue: 117005000 Open source Operating Cash Flow: -201281000 Open source Capital Expenditure: 20927000 Open source
20232023-12-31	Free cash flow margin	-145%	Revenue: 285100000 Open source Operating Cash Flow: -393300000 Open source Capital Expenditure: 20100000 Open source
20242024-12-31	Free cash flow margin	-25.2%	Revenue: 627300000 Open source Operating Cash Flow: -144000000 Open source Capital Expenditure: 14100000 Open source
20252025-12-31	Free cash flow margin	-12.5%	Revenue: 1028900000 Open source Operating Cash Flow: -100200000 Open source Capital Expenditure: 28600000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -100.2M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Operating cash flow	307682000	Operating Cash Flow: 307682000 Open source
20192019-12-31	Operating cash flow	-83065000	Operating Cash Flow: -83065000 Open source
20202020-12-31	Operating cash flow	-223005000	Operating Cash Flow: -223005000 Open source
20212021-12-31	Operating cash flow	-198465000	Operating Cash Flow: -198465000 Open source
20222022-12-31	Operating cash flow	-201281000	Operating Cash Flow: -201281000 Open source
20232023-12-31	Operating cash flow	-393300000	Operating Cash Flow: -393300000 Open source
20242024-12-31	Operating cash flow	-144000000	Operating Cash Flow: -144000000 Open source
20252025-12-31	Operating cash flow	-100200000	Operating Cash Flow: -100200000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -128.8M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Free cash flow	286724000	Operating Cash Flow: 307682000 Open source Capital Expenditure: 20958000 Open source
20192019-12-31	Free cash flow	-109838000	Operating Cash Flow: -83065000 Open source Capital Expenditure: 26773000 Open source
20202020-12-31	Free cash flow	-249259000	Operating Cash Flow: -223005000 Open source Capital Expenditure: 26254000 Open source
20212021-12-31	Free cash flow	-240662000	Operating Cash Flow: -198465000 Open source Capital Expenditure: 42197000 Open source
20222022-12-31	Free cash flow	-222208000	Operating Cash Flow: -201281000 Open source Capital Expenditure: 20927000 Open source
20232023-12-31	Free cash flow	-413400000	Operating Cash Flow: -393300000 Open source Capital Expenditure: 20100000 Open source
20242024-12-31	Free cash flow	-158100000	Operating Cash Flow: -144000000 Open source Capital Expenditure: 14100000 Open source
20252025-12-31	Free cash flow	-128800000	Operating Cash Flow: -100200000 Open source Capital Expenditure: 28600000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

42.2% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2018-12-31	Liabilities / assets	Not reported	No source recorded
20192019-12-31	Liabilities / assets	142.7%	Total Liabilities: 410584000 Open source Total Assets: 287715000 Open source
20202020-12-31	Liabilities / assets	17.2%	Total Liabilities: 124322000 Open source Total Assets: 722093000 Open source
20212021-12-31	Liabilities / assets	31.6%	Total Liabilities: 353521000 Open source Total Assets: 1119465000 Open source
20222022-12-31	Liabilities / assets	44.1%	Total Liabilities: 586651000 Open source Total Assets: 1330963000 Open source
20232023-12-31	Liabilities / assets	32.3%	Total Liabilities: 597238000 Open source Total Assets: 1848609000 Open source
20242024-12-31	Liabilities / assets	37.7%	Total Liabilities: 629600000 Open source Total Assets: 1670200000 Open source
20252025-12-31	Liabilities / assets	42.2%	Total Liabilities: 731600000 Open source Total Assets: 1733700000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.96× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2018-12-31	Current assets / current liabilities	Not reported	No source recorded
20192019-12-31	Current assets / current liabilities	1.62×	Current Assets: 207104000 Open source Current Liabilities: 127761000 Open source
20202020-12-31	Current assets / current liabilities	5.14×	Current Assets: 593944000 Open source Current Liabilities: 115567000 Open source
20212021-12-31	Current assets / current liabilities	4.14×	Current Assets: 949850000 Open source Current Liabilities: 229204000 Open source
20222022-12-31	Current assets / current liabilities	3.69×	Current Assets: 1099119000 Open source Current Liabilities: 297788000 Open source
20232023-12-31	Current assets / current liabilities	6.92×	Current Assets: 1497799000 Open source Current Liabilities: 216418000 Open source
20242024-12-31	Current assets / current liabilities	4.62×	Current Assets: 1283900000 Open source Current Liabilities: 277700000 Open source
20252025-12-31	Current assets / current liabilities	1.96×	Current Assets: 1247100000 Open source Current Liabilities: 636400000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-01 – 2018-12-31	−USD 2.78 million Exact value Exact value: -2784000 USD 2018-01-01 – 2018-12-31: -2784000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Legend Biotech Corporation · 2018-12-31 Legend Biotech Corporation (edgar:1801198) Net Income: -2784000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2784000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000156459021017439/legn-20201231.xml#277871 Filing: 000156459021017439 The citation records this snapshot. The page link may show a newer release later.	USD 307.68 million Exact value Exact value: 307682000 USD 2018-01-01 – 2018-12-31: 307682000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Legend Biotech Corporation · 2018-12-31 Legend Biotech Corporation (edgar:1801198) Operating Cash Flow: 307682000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 307682000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000156459021017439/legn-20201231.xml#319771 Filing: 000156459021017439 The citation records this snapshot. The page link may show a newer release later.	USD 20.96 million Exact value Exact value: 20958000 USD 2018-01-01 – 2018-12-31: 20958000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Legend Biotech Corporation · 2018-12-31 Legend Biotech Corporation (edgar:1801198) Capital Expenditure: 20958000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20958000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000156459021017439/legn-20201231.xml#320505 Filing: 000156459021017439 The citation records this snapshot. The page link may show a newer release later.	USD 286.72 million Calculation and evidence 307682000 − 20958000 USD Exact free cash flow: 286724000 USD 2018-01-01 – 2018-12-31: 307682000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 20958000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Legend Biotech Corporation · 2018-12-31 Legend Biotech Corporation (edgar:1801198) Free cash flow: 286724000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 307682000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000156459021017439/legn-20201231.xml#319771 Filing: 000156459021017439 Input fundies:CapitalExpenditure: 20958000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000156459021017439/legn-20201231.xml#320505 Filing: 000156459021017439 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 101.59 million Exact value Exact value: -101590000 USD 2019-01-01 – 2019-12-31: -101590000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Legend Biotech Corporation · 2019-12-31 Legend Biotech Corporation (edgar:1801198) Net Income: -101590000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -101590000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000156459023002041/legn-20fa_20211231.htm#8680254 Filing: 000156459023002041 The citation records this snapshot. The page link may show a newer release later.	−USD 83.07 million Exact value Exact value: -83065000 USD 2019-01-01 – 2019-12-31: -83065000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Legend Biotech Corporation · 2019-12-31 Legend Biotech Corporation (edgar:1801198) Operating Cash Flow: -83065000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -83065000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000156459023002041/legn-20fa_20211231.htm#7815623 Filing: 000156459023002041 The citation records this snapshot. The page link may show a newer release later.	USD 26.77 million Exact value Exact value: 26773000 USD 2019-01-01 – 2019-12-31: 26773000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Legend Biotech Corporation · 2019-12-31 Legend Biotech Corporation (edgar:1801198) Capital Expenditure: 26773000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 26773000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000156459023002041/legn-20fa_20211231.htm#7838731 Filing: 000156459023002041 The citation records this snapshot. The page link may show a newer release later.	−USD 109.84 million Calculation and evidence -83065000 − 26773000 USD Exact free cash flow: -109838000 USD 2019-01-01 – 2019-12-31: -83065000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 26773000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Legend Biotech Corporation · 2019-12-31 Legend Biotech Corporation (edgar:1801198) Free cash flow: -109838000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -83065000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000156459023002041/legn-20fa_20211231.htm#7815623 Filing: 000156459023002041 Input fundies:CapitalExpenditure: 26773000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000156459023002041/legn-20fa_20211231.htm#7838731 Filing: 000156459023002041 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 266.37 million Exact value Exact value: -266373000 USD 2020-01-01 – 2020-12-31: -266373000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Legend Biotech Corporation · 2020-12-31 Legend Biotech Corporation (edgar:1801198) Net Income: -266373000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -266373000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119823000019/legn-20221231.htm#3115040 Filing: 000180119823000019 The citation records this snapshot. The page link may show a newer release later.	−USD 223.01 million Exact value Exact value: -223005000 USD 2020-01-01 – 2020-12-31: -223005000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Legend Biotech Corporation · 2020-12-31 Legend Biotech Corporation (edgar:1801198) Operating Cash Flow: -223005000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -223005000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119823000019/legn-20221231.htm#2633034 Filing: 000180119823000019 The citation records this snapshot. The page link may show a newer release later.	USD 26.25 million Exact value Exact value: 26254000 USD 2020-01-01 – 2020-12-31: 26254000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Legend Biotech Corporation · 2020-12-31 Legend Biotech Corporation (edgar:1801198) Capital Expenditure: 26254000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 26254000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119823000019/legn-20221231.htm#2641196 Filing: 000180119823000019 The citation records this snapshot. The page link may show a newer release later.	−USD 249.26 million Calculation and evidence -223005000 − 26254000 USD Exact free cash flow: -249259000 USD 2020-01-01 – 2020-12-31: -223005000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 26254000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Legend Biotech Corporation · 2020-12-31 Legend Biotech Corporation (edgar:1801198) Free cash flow: -249259000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -223005000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119823000019/legn-20221231.htm#2633034 Filing: 000180119823000019 Input fundies:CapitalExpenditure: 26254000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119823000019/legn-20221231.htm#2641196 Filing: 000180119823000019 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 403.58 million Exact value Exact value: -403582000 USD 2021-01-01 – 2021-12-31: -403582000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Legend Biotech Corporation · 2021-12-31 Legend Biotech Corporation (edgar:1801198) Net Income: -403582000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -403582000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119824000021/legn-20231231.htm#3090809 Filing: 000180119824000021 The citation records this snapshot. The page link may show a newer release later.	−USD 198.47 million Exact value Exact value: -198465000 USD 2021-01-01 – 2021-12-31: -198465000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Legend Biotech Corporation · 2021-12-31 Legend Biotech Corporation (edgar:1801198) Operating Cash Flow: -198465000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -198465000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119824000021/legn-20231231.htm#2598590 Filing: 000180119824000021 The citation records this snapshot. The page link may show a newer release later.	USD 42.2 million Exact value Exact value: 42197000 USD 2021-01-01 – 2021-12-31: 42197000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Legend Biotech Corporation · 2021-12-31 Legend Biotech Corporation (edgar:1801198) Capital Expenditure: 42197000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 42197000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119824000021/legn-20231231.htm#2606437 Filing: 000180119824000021 The citation records this snapshot. The page link may show a newer release later.	−USD 240.66 million Calculation and evidence -198465000 − 42197000 USD Exact free cash flow: -240662000 USD 2021-01-01 – 2021-12-31: -198465000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 42197000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Legend Biotech Corporation · 2021-12-31 Legend Biotech Corporation (edgar:1801198) Free cash flow: -240662000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -198465000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119824000021/legn-20231231.htm#2598590 Filing: 000180119824000021 Input fundies:CapitalExpenditure: 42197000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119824000021/legn-20231231.htm#2606437 Filing: 000180119824000021 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 446.35 million Exact value Exact value: -446349000 USD 2022-01-01 – 2022-12-31: -446349000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Legend Biotech Corporation · 2022-12-31 Legend Biotech Corporation (edgar:1801198) Net Income: -446349000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -446349000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119825000012/legn-20241231.htm#2344008 Filing: 000180119825000012 The citation records this snapshot. The page link may show a newer release later.	−USD 201.28 million Exact value Exact value: -201281000 USD 2022-01-01 – 2022-12-31: -201281000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Legend Biotech Corporation · 2022-12-31 Legend Biotech Corporation (edgar:1801198) Operating Cash Flow: -201281000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -201281000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119825000012/legn-20241231.htm#2615191 Filing: 000180119825000012 The citation records this snapshot. The page link may show a newer release later.	USD 20.93 million Exact value Exact value: 20927000 USD 2022-01-01 – 2022-12-31: 20927000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Legend Biotech Corporation · 2022-12-31 Legend Biotech Corporation (edgar:1801198) Capital Expenditure: 20927000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20927000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119825000012/legn-20241231.htm#2623542 Filing: 000180119825000012 The citation records this snapshot. The page link may show a newer release later.	−USD 222.21 million Calculation and evidence -201281000 − 20927000 USD Exact free cash flow: -222208000 USD 2022-01-01 – 2022-12-31: -201281000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 20927000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Legend Biotech Corporation · 2022-12-31 Legend Biotech Corporation (edgar:1801198) Free cash flow: -222208000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -201281000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119825000012/legn-20241231.htm#2615191 Filing: 000180119825000012 Input fundies:CapitalExpenditure: 20927000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119825000012/legn-20241231.htm#2623542 Filing: 000180119825000012 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 518.25 million Exact value Exact value: -518254000 USD 2023-01-01 – 2023-12-31: -518254000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Legend Biotech Corporation · 2023-12-31 Legend Biotech Corporation (edgar:1801198) Net Income: -518254000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -518254000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119825000012/legn-20241231.htm#2343404 Filing: 000180119825000012 The citation records this snapshot. The page link may show a newer release later.	−USD 393.3 million Exact value Exact value: -393300000 USD 2023-01-01 – 2023-12-31: -393300000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Legend Biotech Corporation · 2023-12-31 Legend Biotech Corporation (edgar:1801198) Operating Cash Flow: -393300000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -393300000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2552955 Filing: 000180119826000008 The citation records this snapshot. The page link may show a newer release later.	USD 20.1 million Exact value Exact value: 20100000 USD 2023-01-01 – 2023-12-31: 20100000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Legend Biotech Corporation · 2023-12-31 Legend Biotech Corporation (edgar:1801198) Capital Expenditure: 20100000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20100000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2562207 Filing: 000180119826000008 The citation records this snapshot. The page link may show a newer release later.	−USD 413.4 million Calculation and evidence -393300000 − 20100000 USD Exact free cash flow: -413400000 USD 2023-01-01 – 2023-12-31: -393300000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 20100000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Legend Biotech Corporation · 2023-12-31 Legend Biotech Corporation (edgar:1801198) Free cash flow: -413400000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -393300000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2552955 Filing: 000180119826000008 Input fundies:CapitalExpenditure: 20100000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2562207 Filing: 000180119826000008 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 177.03 million Exact value Exact value: -177026000 USD 2024-01-01 – 2024-12-31: -177026000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Legend Biotech Corporation · 2024-12-31 Legend Biotech Corporation (edgar:1801198) Net Income: -177026000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -177026000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119825000012/legn-20241231.htm#2342800 Filing: 000180119825000012 The citation records this snapshot. The page link may show a newer release later.	−USD 144 million Exact value Exact value: -144000000 USD 2024-01-01 – 2024-12-31: -144000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Legend Biotech Corporation · 2024-12-31 Legend Biotech Corporation (edgar:1801198) Operating Cash Flow: -144000000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -144000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2552022 Filing: 000180119826000008 The citation records this snapshot. The page link may show a newer release later.	USD 14.1 million Exact value Exact value: 14100000 USD 2024-01-01 – 2024-12-31: 14100000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Legend Biotech Corporation · 2024-12-31 Legend Biotech Corporation (edgar:1801198) Capital Expenditure: 14100000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14100000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2561421 Filing: 000180119826000008 The citation records this snapshot. The page link may show a newer release later.	−USD 158.1 million Calculation and evidence -144000000 − 14100000 USD Exact free cash flow: -158100000 USD 2024-01-01 – 2024-12-31: -144000000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 14100000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Legend Biotech Corporation · 2024-12-31 Legend Biotech Corporation (edgar:1801198) Free cash flow: -158100000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -144000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2552022 Filing: 000180119826000008 Input fundies:CapitalExpenditure: 14100000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2561421 Filing: 000180119826000008 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	Unavailable Not reported for this period.	−USD 100.2 million Exact value Exact value: -100200000 USD 2025-01-01 – 2025-12-31: -100200000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Legend Biotech Corporation · 2025-12-31 Legend Biotech Corporation (edgar:1801198) Operating Cash Flow: -100200000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -100200000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2551089 Filing: 000180119826000008 The citation records this snapshot. The page link may show a newer release later.	USD 28.6 million Exact value Exact value: 28600000 USD 2025-01-01 – 2025-12-31: 28600000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Legend Biotech Corporation · 2025-12-31 Legend Biotech Corporation (edgar:1801198) Capital Expenditure: 28600000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 28600000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2560635 Filing: 000180119826000008 The citation records this snapshot. The page link may show a newer release later.	−USD 128.8 million Calculation and evidence -100200000 − 28600000 USD Exact free cash flow: -128800000 USD 2025-01-01 – 2025-12-31: -100200000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 28600000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Legend Biotech Corporation · 2025-12-31 Legend Biotech Corporation (edgar:1801198) Free cash flow: -128800000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:05:39Z Snapshot: 41c294c5e473582ed986ca7bc7474440b225b6e429ae07baed7625eb1da214ea Dimensions: Consolidated View: https://fundies.io/companies/edgar/1801198?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -100200000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2551089 Filing: 000180119826000008 Input fundies:CapitalExpenditure: 28600000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm#2560635 Filing: 000180119826000008 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

198 filings · 1,325 latest values · 1,325 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001801198, 1801198, LEGN, edgar:1801198

Also known as LEGEND BIOTECH CORPORATION, Legend Biotech Corp, Legend Biotech Corporation

Legend Biotech Corporation

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation